Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease
Targeting the Pre-supplementary Motor Area With Repetitive Transcranial Magnetic Stimulation to Alleviate Levodopa-induced Dyskinesia in Parkinson´s Disease
Sponsor: Danish Movement Disorder Society (DANMODIS)
Listed as NCT03354455, this NA trial focuses on Dyskinesia, Drug-Induced and Parkinson Disease and remains completed. Sponsored by Danish Movement Disorder Society (DANMODIS), it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2018 — Sep 2019 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danish Movement Disorder Society (DANMODIS)
- Danish Parkinson Association
- Danish Research Centre for Magnetic Resonance
- University Hospital Bispebjerg and Frederiksberg
For direct contact, visit the study record on ClinicalTrials.gov .